LTD insurer now agrees I was disabled — but denying claim under pre-existing condition clause. Need ERISA/LTD advice.
TL;DR:
Insurance company originally denied my LTD claim saying there wasn’t enough evidence I was disabled during the elimination period. After appeal and additional records, they now agree I was unable to work due to substance-related psychiatric impairment and residential treatment — but are now denying payment under a pre-existing condition clause. I’m trying to determine whether this is a potentially winnable ERISA/LTD appeal and whether a clarification letter from my prior psychiatrist could realistically help.
---
Location: New York / Florida (ERISA employer-sponsored LTD policy)
---
I’m looking for advice from anyone familiar with LTD appeals, ERISA, disability insurance, or pre-existing condition disputes.
I worked full-time as a First Aid & Safety Sales Representative for a Fortune 500 company beginning May 2025. My LTD coverage became effective June 13, 2025 after the waiting period.
My job involved extensive driving, territory management, customer interaction, organization, independent scheduling, emotional regulation, and maintaining a demanding workload with minimal supervision.
I stopped working September 26, 2025.
The core issue is this:
The insurance company has since agreed that I was in fact functionally impaired and unable to work due to substance-related psychiatric impairment and ongoing residential treatment. However, they are now denying payment under the policy’s pre-existing condition clause.
Timeline:
- Prior to this job, I had completed opioid treatment in 2023 and remained abstinent from opioids afterward.
- Before and during the early part of my employment, I was being treated for anxiety/depression/PTSD by “Psychiatrist A.”
- During that same period, Psychiatrist A prescribed Valium and later Fioricet (contains butalbital/barbiturate).
- Over time, the Valium/barbiturate use escalated significantly and my occupational functioning deteriorated.
- I eventually entered detox and then residential treatment specifically due to the escalating sedative/barbiturate dependence and resulting functional impairment.
The insurance company originally denied LTD claiming there was insufficient evidence I was disabled during the elimination period.
I appealed and submitted:
- therapist records
- treatment records
- detox records
- residential treatment records
- outpatient addiction medicine records
- pharmacy history
- statements from current treatment providers
After reviewing the additional records, the insurer’s own addiction psychiatry reviewer changed his opinion and agreed that I was functionally impaired and unable to work.
One important detail:
During earlier communications, the insurer initially appeared to characterize the claim as opioid-related and suggested that opioid dependence was part of the pre-existing condition analysis.
I clarified that I had remained abstinent from opioids since 2023 and that the treatment at issue was specifically related to escalating dependence on prescribed Valium and Fioricet/butalbital.
After that clarification, the insurer shifted focus and stated that the pre-existing issue was instead anxiety/depression/PTSD treatment during the policy lookback period.
Their current position is essentially:
- anxiety/depression/PTSD existed before coverage,
- therefore the later disability is considered part of the same condition.
My position is:
- yes, I had pre-existing anxiety/depression diagnoses,
- BUT I was actively working and functioning after coverage began,
- and the disabling condition developed later through escalating dependence on prescribed Valium and Fioricet/butalbital which significantly impaired my occupational functioning and ultimately led to detox/residential treatment.
One complicating issue:
When I entered treatment, the facilities documented anxiety/depression as co-occurring diagnoses because they asked for prior diagnosis history. The insurer is now heavily relying on those diagnoses to characterize the entire disability as pre-existing.
Another complication:
The same company approved my STD claim using many of these same records, but later denied LTD claiming records were missing during the LTD process. During that delay/review period, my employer eventually terminated my employment because they could no longer hold my position.
Another major complication:
“Psychiatrist A” was also the physician who prescribed the Valium and Fioricet/butalbital that later became part of the disabling substance dependence issue.
The office previously provided records during the claim process without issue, but they are now stating that any clarification/support letter would require a telehealth appointment first.
Unfortunately, I lost my employer-sponsored insurance after termination and now only have NY Medicaid, which this Florida-based office does not accept. That means I would likely need to pay out-of-pocket for the appointment.
Part of my hesitation is:
- I do not know whether the psychiatrist would actually agree to write the clarification letter,
- and even if she did, I do not know whether the insurer would consider it sufficient to overcome the pre-existing condition determination.
So I’m trying to determine whether pursuing that route is strategically worthwhile before spending additional money and time.
I currently have about a week to respond to the latest appeal position.
I’m considering asking my prior psychiatric provider for a clarification/support letter explaining:
- the anxiety/depression existed before employment but were not occupationally disabling at that time,
- I was able to work after coverage became active,
- and the later disabling impairment was driven by escalating prescribed sedative/barbiturate dependence and resulting functional decline.
My questions:
Does this seem like a potentially winnable ERISA/LTD argument?
Would a clarification/support letter from the psychiatric provider realistically help?
Is there a meaningful distinction legally/administratively between:
- stable pre-existing anxiety/depression
vs.
- later occupational impairment caused by escalating prescribed sedative/barbiturate dependence?Does the insurer’s apparent shift from initially focusing on “opioid dependence” to now focusing on anxiety/depression/PTSD raise any strategic or procedural concerns?
Is there anything else strategically I should be focusing on before the final appeal decision?
My biggest concern is preserving stability in recovery while trying to navigate an increasingly technical administrative process with limited resources and time remaining.
I genuinely appreciate any insight. This process has been going on since January, and I’m trying to make the most informed decisions possible before the final appeal review.